| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INFA | Class A Common Stock | Options Exercise | $87.2K | +10K | +6.64% | $8.70 | 161K | Apr 15, 2024 | Direct | F1 |
| transaction | INFA | Class A Common Stock | Sale | -$251K | -7.13K | -4.43% | $35.14 | 154K | Apr 15, 2024 | Direct | F1, F2, F3 |
| transaction | INFA | Class A Common Stock | Sale | -$64.3K | -1.79K | -1.17% | $35.86 | 152K | Apr 15, 2024 | Direct | F1, F2, F4 |
| transaction | INFA | Class A Common Stock | Sale | -$41.1K | -1.1K | -0.72% | $37.38 | 151K | Apr 15, 2024 | Direct | F1, F2, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INFA | Stock Option (right to buy) | Options Exercise | $0 | -7.08K | -30.27% | $0.00 | 16.3K | Apr 15, 2024 | Class A Common Stock | 7.08K | $8.70 | Direct | F6 |
| transaction | INFA | Stock Option (right to buy) | Options Exercise | $0 | -2.95K | -9.82% | $0.00 | 27.1K | Apr 15, 2024 | Class A Common Stock | 2.95K | $8.70 | Direct | F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Includes previously reported Restricted Stock Units. |
| F2 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2023. |
| F3 | This sale price represents the weighted average sale price of the shares sold ranging from $34.61 to $35.60 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F4 | This sale price represents the weighted average sale price of the shares sold ranging from $35.61 to $36.14 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F5 | This sale price represents the weighted average sale price of the shares sold ranging from $36.92 to $37.90 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F6 | This performance-based stock option was granted on January 24, 2017. On February 23, 2022, the Company's board of directors certified partial achievement (77%) of the goal based on performance to date and amended the option to provide that 77% of the shares (25,724 shares) covered by the option shall vest over three years, of which 33% shall vest on October 27, 2022 and 8.375% shall vest quarterly thereafter, subject to the Reporting Person remaining in continuous service through each vesting date. The performance period for achievement of the full performance goal remains intact and all shares will vest on achievement of the goal (assuming continued employment through goal achievement). |
| F7 | This performance-based stock option was granted on March 20, 2018. On February 23, 2022, the Company's board of directors certified partial achievement (77%) of the goal based on performance to date and amended the option to provide that 77% of the shares (23,100 shares) covered by the option shall vest over three years, of which 33% shall vest on October 27, 2022 and 8.375% shall vest quarterly thereafter, subject to the Reporting Person remaining in continuous service through each vesting date. The performance period for achievement of the full performance goal remains intact and all shares will vest on achievement of the goal (assuming continued employment through goal achievement). |